Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.50 |
| ▸ | PRKACA | P17612 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31349171 | 0.86 | ALDH1A1 (0.61) | TDP1ALDH1A1TSHRCYP3A4ALOX15 | |
| SCHEMBL6404321 | 0.86 | ALDH1A1 (0.61) | TDP1ALDH1A1TSHRCYP3A4ALOX15 | |
| SCHEMBL2332563 | 0.84 | TDP1 (0.47) | TDP1ALDH1A1TSHRCYP3A4ALOX15 | |
| SCHEMBL17742439 | 0.81 | TDP1 (0.66) | TDP1ALDH1A1CYP3A4MEN1KMT2A | |
| SCHEMBL2327167 | 0.81 | NPC1 (0.45) | TDP1ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL15461976 | 0.81 | ALDH1A1 (0.69) | TDP1ALDH1A1TSHRCYP3A4MEN1 | |
| SCHEMBL10713235 | 0.80 | TDP1 (0.58) | TDP1ALDH1A1TSHRCYP3A4ALOX15 | |
| SCHEMBL10904251 | 0.80 | ALDH1A1 (0.63) | TDP1ALDH1A1TSHRMAPK1CRHBP | |
| SCHEMBL22007056 | 0.79 | ALDH1A1 (0.67) | TDP1ALDH1A1TSHRCYP3A4MEN1 | |
| SCHEMBL11792031 | 0.79 | ALDH1A1 (0.88) | TDP1ALDH1A1TSHRCYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117247515-A | Polyimide containing Trringer's Base element and gas separation membrane and method prepared by polyimide | 西北工业大学 | 2023-12-19 | — | — | CN | claimed |
| CN-116854913-A | Preparation method of high-impact-resistance bismaleimide resin | 西北工业大学 | 2023-10-10 | — | — | CN | claimed |
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| CN-117247515-A | Polyimide containing Trringer's Base element and gas separation membrane and method prepared by polyimide | 西北工业大学 | 2023-12-19 | — | — | CN | disclosed |
| CN-116854913-A | Preparation method of high-impact-resistance bismaleimide resin | 西北工业大学 | 2023-10-10 | — | — | CN | disclosed |
| CN-116375760-A | Diamine containing DDSQ element and polyimide gas separation membrane prepared from diamine and method | 西北工业大学 | 2023-07-04 | — | — | CN | disclosed |
| US-20230174470-A1 | COMPOUND AS A UBR BOX DOMAIN LIGAND | AUTOTAC INC. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-20230174470-A1 | COMPOUND AS A UBR BOX DOMAIN LIGAND | AUTOTAC INC. (KR) | 2023-06-08 | — | — | US | disclosed |
| WO-2023074936-A1 | BIFUNCTIONAL COMPOUND USING UBR BOX DOMAIN-BINDING LIGAND | 주식회사 오토텍바이오 | 2023-05-04 | — | — | WO | disclosed |
| EP-4144722-A1 | COMPOUND AS UBR BOX DOMAIN LIGAND | Autotac Inc. (KR) | 2023-03-08 | — | — | EP | disclosed |
| EP-0635483-B1 | Process for preparing nitroaniline derivatives | SUMITOMO CHEMICAL CO (JP) | 1997-10-22 | — | — | EP | disclosed |
| US-5466871-A | Amination of a nitrobenzene with a hydroxylamine | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0635483-A1 | Process for preparing nitroaniline derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174470-A1 | COMPOUND AS A UBR BOX DOMAIN LIGAND | UBR4, UBQLN2, UBTF | TDP1 3622/4885ALDH1A1 2317/4885TSHR 2205/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | TDP1 3804/4885ALDH1A1 1486/4885TSHR 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.